Reaction
Optic Nerve Disorder reporting signals
As of the last recalculation, Optic Nerve Disorder appears in 1,583 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is BRINZOLAMIDE (PRR 19.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brinzolamide | 13 | 19.8 | 19.9 |
| Latanoprost | 45 | 12.1 | 12.1 |
| Pegaspargase | 11 | 11.9 | 11.9 |
| Vigabatrin | 13 | 11.8 | 11.8 |
| Dorzolamide Hydrochloride And Timolol Maleate | 7 | 11.7 | 11.7 |
| Fingolimod Hcl | 67 | 10.6 | 10.6 |
| Linezolid | 17 | 7.6 | 7.6 |
| Interferon Beta-1A | 104 | 7.5 | 7.5 |
| Brimonidine Tartrate | 9 | 6.7 | 6.7 |
| Ranibizumab | 13 | 6.5 | 6.5 |
| Peginterferon Beta-1A | 6 | 6.0 | 6.0 |
| Ofatumumab | 14 | 5.6 | 5.6 |
| Aflibercept | 13 | 5.5 | 5.5 |
| Asfotase Alfa | 4 | 5.3 | 5.3 |
| Bimatoprost | 11 | 5.0 | 5.0 |
| Faricimab | 3 | 4.9 | 4.9 |
| Travoprost | 3 | 4.6 | 4.6 |
| Natalizumab | 61 | 4.5 | 4.6 |
| Siponimod | 3 | 4.4 | 4.4 |
| Diroximel Fumarate | 4 | 4.4 | 4.4 |
| Teriflunomide | 15 | 4.4 | 4.4 |
| Crizotinib | 4 | 4.1 | 4.1 |
| Encorafenib | 3 | 4.0 | 4.0 |
| Dimethyl Fumarate | 33 | 3.6 | 3.6 |